Litcius/Paper detail

Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial

William F Fearon, Frederik M. Zimmermann, Victoria Y. Ding, Kuniaki Takahashi, Zsolt Piróth, Albert H.M. van Straten, L Székely, Giedrius Davidavičius, Gintaras Kalinauskas, Samer Mansour, Rajesh Kharbanda, Nikolaos Östlund-Papadogeorgos, Adel Aminian, Keith G. Oldroyd, Nawwar Al‐Attar, Nikola Jagić, Jan‐Henk E. Dambrink, Petr Kala, Oskar Angerås, Philip MacCarthy, Olaf Wendler, Filip Casselman, Nils Witt, Kreton Mavromatis, Steven E.S. Miner, Jaydeep Sarma, Thomas Engstrøm, Evald Høj Christiansen, Pim A.L. Tonino, Michael J. Reardon, Hisao Otsuki, Yuhei Kobayashi, Mark A. Hlatky, Kenneth W. Mahaffey, Manisha Desai, Y. Joseph Woo, Alan C. Yeung, Nico H.J. Pijls, Bernard De Bruyne

2025The Lancet40 citationsDOI

Topics & Concepts

Fractional flow reserveMedicineBypass graftingPercutaneous coronary interventionOpen labelArteryCardiologyRandomized controlled trialInternal medicineSurgeryCoronary angiographyMyocardial infarctionCoronary Interventions and DiagnosticsMechanical Circulatory Support DevicesAcute Myocardial Infarction Research
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial | Litcius